Noninferiority drug trials fail to report adequate methodological detail: an assessment of noninferiority trials from 2010 to 2015

被引：1
|
作者：
Hong, Jenny [1 ]
Tung, Anthony [2 ]
Kinkade, Angus [3 ]
Tejani, Aaron M. [4 ]
机构：
[1] Univ British Columbia, Fac Pharmaceut Sci, 2405 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada
[2] Lower Mainland Pharm Serv, 9750 140 St, Surrey, BC V3T 0G9, Canada
[3] Lower Mainland Pharm Serv, 2733 Heather St, Vancouver, BC V5Z 1M9, Canada
[4] Univ British Columbia, Fac Med, Therapeut Initiat, 2176 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada
来源：
JOURNAL OF CLINICAL EPIDEMIOLOGY | 2019年 / 108卷
关键词：
D O I：
10.1016/j.jclinepi.2018.11.028
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：144 / 146
页数：3
相关论文
共 50 条
  • [1] Methodological quality of oncology noninferiority clinical trials
    Wayant, Cole
    Ross, Andrew
    Vassar, Matt
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2020, 149
  • [2] Analyzing noninferiority trials: it is time for advantage deficit assessment - an observational study of published noninferiority trials
    Gladstone, Beryl Primrose
    Vach, Werner
    [J]. OPEN ACCESS JOURNAL OF CLINICAL TRIALS, 2015, 7 : 11 - 21
  • [3] Noninferiority Trials to Evaluate Drug Effects in Rheumatoid Arthritis
    Rothwell, Rebecca
    Nikolov, Nikolay P.
    Maynard, Janet W.
    Levin, Gregory
    [J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72 (08) : 1258 - 1265
  • [4] Endpoint selection for noninferiority percutaneous coronary intervention trials: a methodological description
    Waliszewski, Matthias
    Rosenberg, Mark
    Rittger, Harald
    Breul, Viktor
    Krackhardt, Florian
    [J]. THERAPEUTIC ADVANCES IN CARDIOVASCULAR DISEASE, 2020, 14
  • [5] Interpretation and Inference in Noninferiority Randomized Controlled Trials in Drug Research
    Wangge, G.
    Klungel, O. H.
    Roes, K. C. B.
    de Boer, A.
    Hoes, A. W.
    Knol, M. J.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 88 (03) : 420 - 423
  • [6] Test for the consistency of noninferiority from multiple clinical trials
    Yan, Xin
    Wang, Morgan C.
    Su, Xiaogang
    [J]. JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2007, 17 (02) : 265 - 278
  • [7] The Need for Combined Assessment of Multiple Outcomes in Noninferiority Trials in Oncology
    Jatoi, Ismail
    Gail, Mitchell H.
    [J]. JAMA ONCOLOGY, 2020, 6 (03) : 420 - 424
  • [8] Reporting of Noninferiority and Equivalence Randomized Trials Extension of the CONSORT 2010 Statement
    Piaggio, Gilda
    Elbourne, Diana R.
    Pocock, Stuart J.
    Evans, Stephen J. W.
    Altman, Douglas G.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (24): : 2594 - 2604
  • [9] Challenges in the Design and Interpretation of Noninferiority Trials Insights From Recent Stent Trials
    Macaya, Fernando
    Ryan, Nicola
    Salinas, Pablo
    Pocock, Stuart J.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (07) : 894 - 903
  • [10] The utility of active-controlled noninferiority/equivalence trials in drug development
    Tsong Y.
    [J]. International Journal of Pharmaceutical Medicine, 2007, 21 (3) : 225 - 233
12345